Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05594745 · ClinicalTrials.gov registry record · Phase 4
Treatment Regimens in Meibomian Gland Dysfunction
A Phase 4 study, sponsored by Tauber Eye Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT05594745: Completed Phase 4 study, sponsored by Tauber Eye Center.
NCT05594745 is a Phase 4 study that has completed, run by Tauber Eye Center. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05594745, a Phase 4 study, has completed, sponsored by Tauber Eye Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study seeks to explore the relevance of inflammation in dry eye patients with MGD and compare the efficacy of LipiFlow treatment followed by lid hygiene and lubricant treatment with Systane Ultra or LipiFlow treatment followed by lid hygiene and lifitegrast treatment in patients with meibomian gland dysfunction.
Primary Outcome
visual analog scale from 0 to 100, higher is worse
Interventions
- DRUG Lifitegrast Ophthalmic
- DRUG Systane Free
- DEVICE Lipiflow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-03-02 |
| Est. Completion | 2023-01-21 |
| Phase | Phase 4 |
What the finished NCT05594745 record still lists
NCT05594745 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 3 interventions - of which Lifitegrast Ophthalmic is the first listed.
NCT05594745 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05594745 about?
NCT05594745 is a clinical study titled "Treatment Regimens in Meibomian Gland Dysfunction". This study seeks to explore the relevance of inflammation in dry eye patients with MGD and compare the efficacy of LipiFlow treatment followed by lid hygiene and lubricant treatment with Systane Ultra or LipiFlow treatment followed by lid hygiene and lifitegrast treatment in patients with meibomian ...
What is the current status of trial NCT05594745?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2021-03-02. Estimated completion is 2023-01-21.
What interventions are being tested in trial NCT05594745?
The interventions under investigation include: Lifitegrast Ophthalmic (DRUG), Systane Free (DRUG), Lipiflow (DEVICE).
Who is sponsoring clinical trial NCT05594745?
This trial is sponsored by Tauber Eye Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05594745's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI